PROTOSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Protostat, and what generic alternatives are available?
Protostat is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in PROTOSTAT is metronidazole. There are eighteen drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Protostat
A generic version of PROTOSTAT was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for PROTOSTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 3,999 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROTOSTAT at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROTOSTAT
US Patents and Regulatory Information for PROTOSTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | PROTOSTAT | metronidazole | TABLET;ORAL | 018871-001 | Mar 2, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ortho Mcneil Pharm | PROTOSTAT | metronidazole | TABLET;ORAL | 018871-002 | Mar 2, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |